ExploreWatchlistsPricing
  1. JP-listed companies
  2. HISAMITSU PHARMACEUTICAL CO.,INC.
  3. Financials
  4. Accounts payable

HISAMITSU PHARMACEUTICAL CO.,INC. (4530)

Market cap
¥514.8B
P/E ratio
19.9x
Hisamitsu Pharmaceutical manufactures and sells over-the-counter medications like allergy treatments, operating globally through subsidiaries in the US, Europe, and Asia.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndAccounts payable (Million JPY)YoY (%)
Feb 28, 202611,245+13.47%
Feb 28, 20259,910+3.10%
Feb 29, 20249,612+15.10%
Feb 28, 20238,351+10.86%
Feb 28, 20227,533-1.81%
Feb 28, 20217,672-26.85%
Feb 29, 202010,488+26.51%
Feb 28, 20198,290+7.54%
Feb 28, 20187,709-3.70%
Feb 28, 20178,005+4.38%
Feb 29, 20167,669-22.75%
Feb 28, 20159,928

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat